Investing
J&J's Earnings Win Muted By Currency Impact (JNJ)
Published:
Last Updated:
DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates. The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues were down 7.4% to $15.2 billion vs. 15.02 billion estimates. Currency was another drag on the company.
As far as the impact of currency, this was sharp. Operational results were down 1.4% and the impact of currency was negative by 6.0%. Operational growth of sales was roughly 3.9%, reflecting a negative currency impact of 11.9%.
Despite the beat on earnings, this marks a 6.7% drop in domestic sales and marks a 8% drop in international sales. Consumer product sales were down 4.5%.
J&J is also backing its annual outlook of $4.45 to $4.55 EPS for 2009. Thomson Reuters has estimates of $4.51.
Shares closed at $57.72 yesterday, and pre-market indications are up over $58.50. Its 52-week trading range is $46.25 to $72.76.
JON C. OGG
JULY 14, 2009
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
